Analysis of the status of spot urine albumin creatinine ratio in pregnancy
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20250876Keywords:
Urinary albumin-to-creatinine ratio, Pregnancy complications, Preeclampsia, Gestational hypertension, Gestational diabetes mellitus, Fetal outcomesAbstract
Introduction: Urinary albumin-to-creatinine ratio (UACR) has been widely studied as a non-invasive biomarker for detecting and predicting complications in pregnancy.
Methods: A prospective cohort of 170 pregnant women was evaluated for UACR levels in all three trimesters. UACR thresholds were derived using receiver operating characteristic (ROC) curve analysis, with clinical diagnoses as the gold standard. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for each threshold.
Results: Mean UACR values increased progressively across trimesters, from 3.6 (±1.9) mg/g in the first trimester to 189.4 (±214.1) mg/g in the third. A UACR threshold of 316 mg/g in the third trimester achieved high diagnostic accuracy for preeclampsia (sensitivity 96.15%, specificity 97.22%, AUC 0.958). Second-trimester thresholds were predictive for preeclampsia (10.6 mg/g; AUC 0.851), GHTN (8 mg/g; AUC 0.5408), and GDM (8.2 mg/g; AUC 0.5409). Fetal complications (8.6 mg/g; AUC 0.6386) and C-sections (8.4 mg/g; AUC 0.5657) were also significantly associated with second-trimester UACR levels.
Conclusion: The study establishes trimester-specific UACR thresholds for identifying and predicting maternal and fetal complications, emphasizing its utility in antenatal care. Incorporating UACR into routine screening could enhance early detection and management of high-risk pregnancies.
Metrics
References
Conrad KP, Davison JM. The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin. Am J Physiol Renal Physiol. 2014;306(10):1121-35. DOI: https://doi.org/10.1152/ajprenal.00042.2014
Lopes van Balen VA, van Gansewinkel TAG, de Haas S, Spaan JJ, Ghossein-Doha C, van Kuijk SMJ, van Drongelen J. Maternal kidney function during pregnancy: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2019;54(3):297-307. DOI: https://doi.org/10.1002/uog.20137
Kliman HJ. Uteroplacental blood flow the story of decidualization, menstruation and trophoblast invasion. Am J Pathol. 2011;157:1759–68. DOI: https://doi.org/10.1016/S0002-9440(10)64813-4
Kozer E, Costei AM, Boskovic R. Effects of aspirin con- sumption during pregnancy on pregnancy outcomes: meta-anal- ysis. Birth Defects Res Part B Dev Reprod Toxicol. 2013;68:70–84. DOI: https://doi.org/10.1002/bdrb.10002
Bujold E, Roberge S, Lacasse Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2012;116:402–14. DOI: https://doi.org/10.1097/AOG.0b013e3181e9322a
Bakris GL. Microalbuminuria: what is it? Why is it important? What should be done about it? J Clin Hypertens (Greenwich). 2001 Mar-Apr;3(2):99-102. doi: 10.1111/j.1524-6175.2001.00442.x. PMID: 11416691; PMCID: PMC8101897. DOI: https://doi.org/10.1111/j.1524-6175.2001.00442.x
Rao S, Somalwar S, Bhalerao A, Raman V. Accuracy of spot urine albumin creatinine ratio with respect to 24-hour urine albumin for the detection of proteinuria in antenatal women with preeclampsia: a descriptive study. Cureus. 2023;15(6):39961. DOI: https://doi.org/10.7759/cureus.39961
Bar J, Hod M, Erman A, Friedman S, Gelerenter I, Kaplan B, Boner G, Ovadia J. Microalbuminuria as an early predictor of hypertensive complications in pregnant women at high risk. American journal of kidney diseases. 1996;28(2):220-5. DOI: https://doi.org/10.1016/S0272-6386(96)90305-4
Poulsen PL, Mogensen CE. Clinical evaluation of a test for immediate and quantitative determination of urinary albumin-to-creatinine ratio. Diabetes Care. 1998;21(1):97. DOI: https://doi.org/10.2337/diacare.21.1.97
Sachan R, Patel ML, Sachan P, Shyam R, Verma P, Dheeman S. Diagnostic accuracy of spot albumin creatinine ratio and its association with fetomaternal outcome in preeclampsia and eclampsia. Niger Med J. 2017;58(2):58-62. DOI: https://doi.org/10.4103/0300-1652.219345
Braunthal S, Brateanu A. Hypertension in pregnancy: pathophysiology and treatment. SAGE Open Med. 2019;7:2050312119843700. DOI: https://doi.org/10.1177/2050312119843700
Gupta N, Gupta T, Asthana D. Prediction of preeclampsia in early pregnancy by estimating the spot urinary albumin/creatinine ratio. The J of Obst and Gynecol of India. 2017;67(4):258-62. DOI: https://doi.org/10.1007/s13224-016-0958-z
Baweja S, Kent A, Masterson R, Roberts S, McMahon LP. Prediction of pre‐eclampsia in early pregnancy by estimating the spot urinary albumin: creatinine ratio using high‐performance liquid chromatography. BJOG: An Int J Obst & Gynaecol. 2011;118(9):1126-32. DOI: https://doi.org/10.1111/j.1471-0528.2011.02960.x
Wikström AK, Wikström J, Larsson A, Olovsson M. Random albumin/creatinine ratio for quantification of proteinuria in manifest pre‐eclampsia. BJOG. 2006;113(8):930-4. DOI: https://doi.org/10.1111/j.1471-0528.2006.01007.x
Mishra VV, Goyal PA, Priyankur R, Choudhary S, Aggarwal RS, Gandhi K, et al. Evaluation of spot urinary albumin–creatinine ratio as screening tool in prediction of pre-eclampsia in early pregnancy. The J of Obst and Gynecol of India. 2017;67(6):405-8. DOI: https://doi.org/10.1007/s13224-016-0950-7
Rajeshwari G, Dongare AG, Patil GL, Pujar T. Evaluation of spot urinary albumin--creatinine ratio as a screening tool in the prediction of pre-eclampsia in early pregnancy: a pilot study. Int J Reprod, Contracep, Obst and Gynecol. 2020;9(2):575-80. DOI: https://doi.org/10.18203/2320-1770.ijrcog20200339
Cheung KL, Lafayette RA. Renal physiology of pregnancy. Adv Chronic Kidney Dis. 2013;20(3):209-14. DOI: https://doi.org/10.1053/j.ackd.2013.01.012
Tonneijck L, Muskiet MH, Smits MM, van Bommel EJ, Heerspink HJ, et al. Glomerular Hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J Am Soc Nephrol. 2017;28(4):1023-39. DOI: https://doi.org/10.1681/ASN.2016060666
Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856-69. DOI: https://doi.org/10.1161/CIRCULATIONAHA.109.853127
Yi J, Chen L, Meng X, Chen Y. Risk factors and foetal growth restriction associated with expectant treatment of early-onset preeclampsia. Ann Med. 2022;54(1):3250-7. DOI: https://doi.org/10.1080/07853890.2022.2144642
Duley L, Henderson-Smart D, Meher S. Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database Syst Rev. 2005;(4):5548. DOI: https://doi.org/10.1002/14651858.CD005548
Ramin SM, Vidaeff AC, Yeomans ER, Gilstrap LC 3rd. Chronic renal disease in pregnancy. Obstet Gynecol. 2006;108(6):1531-9. DOI: https://doi.org/10.1097/01.AOG.0000246790.84218.44
Downloads
Published
How to Cite
Issue
Section
